
Radiopharmaceuticals: The Next Frontier in Precision Cancer Care
Radiopharmaceuticals are emerging as the future of cancer care, combining targeted precision with powerful radiation to deliver safer, more effective treatments.
Radiopharmaceuticals are emerging as the future of cancer care, combining targeted precision with powerful radiation to deliver safer, more effective treatments.
Biotech companies are racing to develop non-opioid pain medications as safer, effective alternatives to addictive opioids, with breakthroughs like Vertex’s FDA-approved Journavx leading a new era in pain management.
Chemical engineer and biotechnology pioneer in controlled drug delivery, mRNA therapeutics, and tissue engineering. Co-founder of Moderna and leader in biomedical innovation.
Jonathan Bush, CEO of Zus Health, shares his vision on how artificial intelligence can transform healthcare by automating administrative tasks and why disruptive innovation is crucial in the sector.
Join us in building the future of medicine through innovative technology and biology convergence